HIGHLIGHTS
- who: Mechanism and collaborators from the Department of Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University, Huaihai West Road, Shanghai, Department of Obstetrics and Gynecology, Jiaozhou Central Hospital of Qingdao, Xuzhou Road of Jiaozhou, Qingdao, China have published the Article: Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy, in the Journal: Journal of Oncology of 12/04/2022
- what: The main reasons for this poor prognosis are the advanced stage at diagnosis, the high rate of disease recurrence, and the eventual emergence of treatment resistance .
- how: Current antiangiogenic therapy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.